🌟 Pharmidex at Medicine at the Crick | New Frontiers in Drug Discovery 🌟
November 18, 2024
We are excited to announce that
Pharmidex will be participating in the Medicine at the Crick | New Frontiers in Drug Discovery meeting! Our Head of Operations,
Ash Alavijeh, will be representing
Pharmidex at this prestigious event.
Ash is looking forward to connecting with fellow attendees, discussing the latest breakthroughs in drug discovery, and exploring opportunities for collaboration.
This meeting is a fantastic platform for exchanging ideas and advancing innovation in medicine come meet us and learn how Pharmidex’s expertise in preclinical research can support your drug discovery journey!
📅 When: 18/11/2024
📍 Where: Francis Crick Institute
We can’t wait to see you there!
#Pharmidex #DrugDiscovery #MedicineAtTheCrick #Collaboration #Innovation
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
Pharmidex is pleased to share that Ash Alavijeh , our Head of Operations, will be attending the Life Sciences Wallonia Business Forum this evening at the Residence of the Belgian Ambassador. Hosted by the Economic Counsellor of Belgium-Wallonia Investment & Trade, the event brings together leading organisations across the European life sciences sector to explore how Wallonia supports international growth both financially and strategically. We look forward to connecting with international partners and exploring opportunities for collaboration and innovation in the European life sciences ecosystem.
Pharmidex is proud to sponsor the SMR meeting Target Identification and Validation in Drug Discovery
We’re excited that Janette Dalay Robertson (Business Development Manager) and Ian Knowles (Head of Respiratory) will attend, eager to meet attendees, share ideas and explore new collaborations to advance drug discovery and development. At Pharmidex , we know robust target validation is key to successful therapeutics. Our expertise in biomarker analysis, histology, in vivo models, and autoimmune disease research supports innovation across translational medicine.
